Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

Current Status and Emerging Options for Automated Insulin Delivery Systems

(2022) Gregory P. Forlenza et al.   Diabetes Technology & Therapeutics

New closed-loop insulin systems

(2021) Charlotte K. Boughton et al.   DIABETOLOGIA

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial

(2021) Charlotte K. Boughton et al.   NATURE MEDICINE

Treatment of type 2 diabetes: challenges, hopes, and anticipated successes

(2021) Michael A Nauck et al.   Lancet Diabetes & Endocrinology

Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen

(2020) Simon R Heller et al.   BMJ Open Diabetes Research & Care

Hybrid closed‐loop therapy: Where are we in 2021?

(2020) Lalantha Leelarathna et al.   DIABETES OBESITY & METABOLISM

Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial

(2019) Charlotte K Boughton et al.   Lancet Diabetes & Endocrinology

Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management

(2019) Stephanie A Amiel et al.   Lancet Diabetes & Endocrinology

Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

(2018) Kamlesh Khunti et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care

(2018) Lia Bally et al.   NEW ENGLAND JOURNAL OF MEDICINE

Type 2 diabetes

(2017) Sudesna Chatterjee et al.   LANCET

Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial

(2017) Hood Thabit et al.   Lancet Diabetes & Endocrinology

New forms of insulin and insulin therapies for the treatment of type 2 diabetes

(2015) Avivit Cahn et al.   Lancet Diabetes & Endocrinology

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

(2008) J. S. Skyler et al.   DIABETES CARE